365564-07-4

Basic information

• Product Name: 2-(3,5-DIMETHOXY)-PHENYL-4,4,5,5-TETRAMETHYL-(1,3,2)-DIOXABOROLANE
• Synonyms: 2-(3,5-DIMETHOXY)-PHENYL-4,4,5,5-TETRAMETHYL-(1,3,2)-DIOXABOROLANE;3,5-DIMETHOXYPHENYLBORONIC ACID, PINACOL ESTER;3,5-Dimethoxyphenylboronic acid pinacol ester 97%
• CAS NO: 365564-07-4
• Molecular Formula: C₁₄H₂₁BO₄
• Molecular Weight: 264.13
• Mol File: 365564-07-4.mol
• Article Data: 58

Chemical Properties

• Melting Point: 90-94 °C(lit.)
• Boiling Point: 374.5°C at 760 mmHg
• Flash Point: 180.3°C
• Appearance: /
• Density: 1.05
• Vapor Pressure: 1.79E-05mmHg at 25°C
• Refractive Index: 1.49
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• CAS DataBase Reference: 2-(3,5-DIMETHOXY)-PHENYL-4,4,5,5-TETRAMETHYL-(1,3,2)-DIOXABOROLANE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3,5-DIMETHOXY)-PHENYL-4,4,5,5-TETRAMETHYL-(1,3,2)-DIOXABOROLANE(365564-07-4)
• EPA Substance Registry System: 2-(3,5-DIMETHOXY)-PHENYL-4,4,5,5-TETRAMETHYL-(1,3,2)-DIOXABOROLANE(365564-07-4)

Safety Data

• Safety Statements: 22-24/25
• WGK Germany: 3
• Hazardous Substances Data: 365564-07-4(Hazardous Substances Data)

Usage

General Description

2-(3,5-Dimethoxy)-phenyl-4,4,5,5-tetramethyl-(1,3,2)-dioxaborolane is a chemical compound with the molecular formula C14H21BO4. It is a boron-containing compound that is commonly used in organic synthesis as a reagent for Suzuki coupling reactions. 2-(3,5-DIMETHOXY)-PHENYL-4,4,5,5-TETRAMETHYL-(1,3,2)-DIOXABOROLANE is a colorless liquid and is often used in the pharmaceutical industry for the synthesis of various drugs and pharmaceutical intermediates. It has also found applications in the field of material science for the preparation of organic electronic materials and polymers. Due to its versatile reactivity and wide range of applications, 2-(3,5-Dimethoxy)-phenyl-4,4,5,5-tetramethyl-(1,3,2)-dioxaborolane is an important chemical in the field of organic chemistry and synthetic chemistry.

InChI:InChI=1/C14H21BO4/c1-13(2)14(3,4)19-15(18-13)10-7-11(16-5)9-12(8-10)17-6/h7-9H,1-6H3

Upstream product

• 25245-27-6 1-iodo-3,5-dimethoxybenzene 
• 73183-34-3 bis(pinacol)diborane 
• 151-10-0 1,3-Dimethoxybenzene 
• 20469-65-2 1-bromo-3,5-dimethoxybenzene 
• 76-09-5 2,3-dimethyl-2,3-butane diol 
• 192182-54-0 3,5-dimethoxyphenylboronic acid 
• 1195-66-0 2-methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 25015-63-8 4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane 
• 500-99-2 3,5-dimethoxyphenol 
• 7051-16-3 1-chloro-3,5-dimethoxybenzene 
• 52189-63-6 3,5-dimethoxyfluorobenzene 

Downstream Products

• 1431793-71-3 6-hydroxy-2,8,10-trimethoxy-4-(2,4-dimethoxyphenyl)dibenz[c,e][1,2]opxaborinin 
• 19179-31-8 3,5-dimethoxy-benzonitrile 
• 158152-56-8 1,3-dimethoxy-5-(trifluoromethyl)benzene 
• 4670-10-4 (3,5-dimethoxyphenyl)acetic acid 
• 1141493-97-1 tert-butyl 2-(3,5-dimethoxyphenyl)acetate 
• 192182-54-0 3,5-dimethoxyphenylboronic acid 
• 1258071-64-5 4-(3,5-dimethoxyphenyl)pentan-2-one 
• 132858-38-9 4-(3,5-dimethoxyphenyl)-3-methylbutan-2-one 
• 1268263-03-1 C₂₀H₂₈N₄O₂S 
• 1202378-13-9 ethyl 4-(3,5-dimethoxyphenyl)-5-(4-fluorophenyl)-6-methyl-3-pyridinecarboxylate 
• 1261352-15-1 methyl 3-amino-6-(3,5-dimethoxyphenyl)thieno[3,2-b]pyridine-2-carboxylate 
• 25939-81-5 1-ethyl-1,2,3,4-tetrahydroisoquinoline 
• 1229227-19-3 C₁₇H₁₉NO₃ 
• 1231714-53-6 2-[2-(4,5-dimethylthiophen-2-yl)-3,5-dimethoxyphenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 

Relevant articles and documents

"Janus-type" ruthenium complex bearing both phosphonic acids and pyrene groups for functionalization of ITO and HOPG surfaces

A novel Janus-type ruthenium complex bearing both phosphonic acid and pyrene groups was tethered to both ITO and HOPG surfaces in different tethering modes. On the ITO surface, the phosphonic groups were selectively attached to the ITO, resulting in the h

Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance

Microtubule targeting agents (MTAs) are among the most successful chemotherapeutic drugs, but their efficacy is often limited by the development of multidrug resistance (MDR). Therefore, the development of novel MTAs with the ability to overcome MDR is urgently needed. In this contribution, through modification of the unsymmetric biaryl compounds, we discovered a novel compound dxy-1-175 with potent anti-proliferative activity against cancer cells. Mechanistic study revealed that dxy-1-175 inhibited tubulin polymerization by interacting with the colchicine-binding site of tubulin, which caused cell cycle arrest at G2/M phase. Based on the predicted binding model of dxy-1-175 with tubulin, a series of new 4-benzoylbiphenyl analogues were designed and synthesized. Among them, the hydrochloride compound 12e with improved solubility and good stability in human liver microsome, exhibited the most potent anti-proliferative activity with IC50 value in the low nanomolar range, and markedly inhibited the growth of breast cancer 4T1 xenograft in vivo. Notably, 12e effectively overcame P-gp-mediated MDR and our preliminary data suggested that 12e may not be a substrate of P-glycoprotein (P-gp). Taken together, our study reveals a novel MTA 12e targeting the colchicine-binding site with potent anticancer activity and the ability to circumvent MDR.

Recyclable Pd2dba3/XPhos/PEG-2000 System for Efficient Borylation of Aryl Chlorides: Practical Access to Aryl Boronates

Pd2dba3/XPhos in poly(ethylene glycol) (PEG-2000) is shown to be a highly stable and efficient catalyst for the borylation of aryl chlorides with bis(pinacolato)diboron. The borylation reaction proceeds smoothly at 110 °C, delivering a wide variety of aryl boronates in good to excellent yields with high functional group tolerance. The crude products were easily isolated via simple extraction of the reaction mixture with cyclohexane. Moreover, both expensive Pd2dba3 and XPhos in PEG-2000 system could be readily recycled and reused more than six times without loss of catalytic efficiency.